We are live on ! Find out more
AAP

Arax Advisory Partners Portfolio holdings

AUM $3.54B
1-Year Est. Return 19.14%
This Fund
S&P 500
This Quarter Est. Return
+8.62%
1 Year Est. Return
+19.14%
3 Year Est. Return
+47.9%
5 Year Est. Return
+48.74%
10 Year Est. Return
AUM
$6.97B
AUM Growth
+$4.79B
Cap. Flow
+$6.91B
Cap. Flow %
99.25%
Top 10 Hldgs %
36.51%
Holding
4,400
New
1,371
Increased
1,984
Reduced
143
Closed
794

Sector Composition

Rank Sector Weight
1 Technology 13.48%
2 Financials 8.05%
3 Industrials 7.03%
4 Consumer Discretionary 6.62%
5 Healthcare 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLSE icon
2826
Pulse Biosciences
PLSE
$2.94B
$5.75K ﹤0.01%
+325
New +$5.14K
RXT icon
2827
Rackspace Technology
RXT
$1.24B
$5.75K ﹤0.01%
+4,075
New +$5.46K
GLRE icon
2828
Greenlight Captial
GLRE
$506M
$5.73K ﹤0.01%
+451
New +$5.89K
MQ icon
2829
Marqeta
MQ
$1.66B
$5.72K ﹤0.01%
271
+210
+344% +$4.98K
FC icon
2830
Franklin Covey
FC
$246M
$5.71K ﹤0.01%
294
+88
+43% +$1.74K
PVLA
2831
Palvella Therapeutics
PVLA
$2.27B
$5.7K ﹤0.01%
+91
New +$4.06K
MAPS
2832
DELISTED
WM TECHNOLOGY INC A
MAPS
$5.7K ﹤0.01%
4,912
+4,852
+8,087% +$5.24K
SKWD icon
2833
Skyward Specialty Insurance
SKWD
$2.58B
$5.66K ﹤0.01%
+119
New +$5.95K
AVNW icon
2834
Aviat Networks
AVNW
$273M
$5.62K ﹤0.01%
+245
New +$5.63K
BPRN icon
2835
Princeton Bancorp
BPRN
$287M
$5.6K ﹤0.01%
+176
New +$5.68K
MNA icon
2836
IQ ARB Merger Arbitrage ETF
MNA
$253M
$5.6K ﹤0.01%
+156
New +$5.55K
ASR icon
2837
Grupo Aeroportuario del Sureste
ASR
$8.3B
$5.6K ﹤0.01%
17
+8
+89% +$2.58K
ARCT icon
2838
Arcturus Therapeutics
ARCT
$211M
$5.55K ﹤0.01%
301
+210
+231% +$3.37K
ANDE icon
2839
Andersons Inc
ANDE
$2.22B
$5.53K ﹤0.01%
139
+113
+435% +$4.35K
LINC icon
2840
Lincoln Educational Services
LINC
$1.3B
$5.45K ﹤0.01%
232
+192
+480% +$4.12K
PBR.A icon
2841
Petrobras Class A
PBR.A
$103B
$5.44K ﹤0.01%
460
-2,655
-85% -$30.7K
QQQX icon
2842
Nuveen NASDAQ 100 Dynamic Overwrite Fund
QQQX
$1.49B
$5.44K ﹤0.01%
+198
New +$5.31K
DAKT icon
2843
Daktronics
DAKT
$1.04B
$5.42K ﹤0.01%
+259
New +$4.65K
CBLL
2844
CeriBell Inc
CBLL
$714M
$5.41K ﹤0.01%
+471
New +$6.35K
JHX icon
2845
James Hardie Industries
JHX
$17.5B
$5.4K ﹤0.01%
281
+223
+384% +$5.34K
COGT icon
2846
Cogent Biosciences
COGT
$7.24B
$5.37K ﹤0.01%
+374
New +$4.43K
TG icon
2847
Tredegar Corp
TG
$310M
$5.36K ﹤0.01%
+667
New +$5.5K
CTOS icon
2848
Custom Truck One Source
CTOS
$2.37B
$5.34K ﹤0.01%
+832
New +$4.82K
WNS
2849
DELISTED
WNS Holdings
WNS
$5.34K ﹤0.01%
70
+54
+338% +$4.04K
ICHR icon
2850
Ichor Holdings
ICHR
$2.56B
$5.33K ﹤0.01%
304
-724
-70% -$13.8K

Similar funds

Arax Advisory Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Arax Advisory Partners held 4,400 positions worth $6.97B, up 220% from $2.18B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Arax Advisory Partners deployed $6.91B of net new capital in Q3 2025, opening 1,371 new positions and adding to 1,984 existing holdings. Its largest new stake was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 6.5% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Axon Enterprise, an estimated $58.1M trimmed.

  • Arax Advisory Partners's largest Q3 2025 buy was American Century Diversified Corporate Bond ETF: 3,224,236 shares worth $194M.
  • Arax Advisory Partners added most to iShares S&P 100 ETF in Q3 2025, an estimated $2.43B increase.
  • Arax Advisory Partners's biggest Q3 2025 reduction was Axon Enterprise, cutting an estimated $58.1M.
  • Arax Advisory Partners fully exited Vanguard Morningstar Growth ETF in Q3 2025, selling an estimated $91.2M.
  • Arax Advisory Partners's ten largest holdings make up 37% of its $6.97B portfolio in Q3 2025.
  • Arax Advisory Partners opened 1,371 new positions and closed 794 in Q3 2025.
  • Arax Advisory Partners's portfolio value rose 220% quarter-over-quarter to $6.97B.

Based on Arax Advisory Partners's 13F filing for Q3 2025, filed 14 Nov 2025.